Correlation Between SentinelOne and DNA Biomed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SentinelOne and DNA Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SentinelOne and DNA Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SentinelOne and DNA Biomed Solns, you can compare the effects of market volatilities on SentinelOne and DNA Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SentinelOne with a short position of DNA Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of SentinelOne and DNA Biomed.

Diversification Opportunities for SentinelOne and DNA Biomed

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between SentinelOne and DNA is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding SentinelOne and DNA Biomed Solns in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DNA Biomed Solns and SentinelOne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SentinelOne are associated (or correlated) with DNA Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DNA Biomed Solns has no effect on the direction of SentinelOne i.e., SentinelOne and DNA Biomed go up and down completely randomly.

Pair Corralation between SentinelOne and DNA Biomed

Taking into account the 90-day investment horizon SentinelOne is expected to under-perform the DNA Biomed. But the stock apears to be less risky and, when comparing its historical volatility, SentinelOne is 2.83 times less risky than DNA Biomed. The stock trades about -0.27 of its potential returns per unit of risk. The DNA Biomed Solns is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  7,580  in DNA Biomed Solns on January 20, 2024 and sell it today you would earn a total of  1,380  from holding DNA Biomed Solns or generate 18.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy90.48%
ValuesDaily Returns

SentinelOne  vs.  DNA Biomed Solns

 Performance 
       Timeline  
SentinelOne 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SentinelOne has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in May 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
DNA Biomed Solns 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DNA Biomed Solns are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, DNA Biomed sustained solid returns over the last few months and may actually be approaching a breakup point.

SentinelOne and DNA Biomed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SentinelOne and DNA Biomed

The main advantage of trading using opposite SentinelOne and DNA Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SentinelOne position performs unexpectedly, DNA Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DNA Biomed will offset losses from the drop in DNA Biomed's long position.
The idea behind SentinelOne and DNA Biomed Solns pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences